GLP-1s may be misused by patients with eating disorders: Study

A recent study reveals that GLP-1 medications, typically used for diabetes and weight management, are being misused by individuals with eating disorders at a higher rate than the general population. This misuse raises concerns about the potential for these drugs to be abused for weight control, highlighting the need for better monitoring and understanding of their effects among vulnerable populations. The findings underscore the importance of addressing the intersection of medical treatments and mental health, particularly in preventing the exploitation of pharmaceuticals for non-prescribed purposes.